FDA Strengthens Warnings on Lariam, an Anti-Malaria Drug

FDA Strengthens Warnings on Lariam, an Anti-Malaria Drug

The Food and Drug Administration announced on Monday that a commonly used anti-malaria drug must carry the so-called black box warning on its label because of the danger that the drug could cause serious neurological and psychiatric side effects, some 

5
Like
Save

Comments

Write a comment

*